Process / pipelineClinical / epidemiology

Retrospective Phase III Clinical Trial

A retrospective Phase III clinical trial evaluates the comparative efficacy and safety of an intervention against a control using data that were collected before the study was designed. Rather than enrolling new patients prospectively, researchers analyze existing records — from registries, hospital databases, or historical trial archives — to address a Phase III-level question: does Treatment A outperform the current standard of care in a large, representative patient population? This design is used when prospective enrollment is infeasible, unethical, or when historical data are sufficiently complete to support a rigorous comparison.

Open in MethodMindSoonVideoSoon

Read the full method

Members only

Sign in with a free account to read this section.

Sign in

Sources

  1. Friedman, L. M., Furberg, C. D., & DeMets, D. L. (2010). Fundamentals of Clinical Trials (4th ed.). Springer. ISBN: 978-1441915856
  2. International Conference on Harmonisation. (1998). ICH E9: Statistical Principles for Clinical Trials. Federal Register, 63(179), 49583–49598. link

Related methods

ScholarGateRetrospective phase III clinical trial (Retrospective Phase III Clinical Trial). Retrieved 2026-06-04 from https://scholargate.app/en/epidemiology/retrospective-phase-iii-clinical-trial